• Je něco špatně v tomto záznamu ?

PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcome

A. Pelet, V. Skopova, U. Steuerwald, V. Baresova, M. Zarhrate, JM. Plaza, A. Hnizda, M. Krijt, O. Souckova, F. Wibrand, G. Andorsdóttir, F. Joensen, D. Sedlak, AJ. Bleyer, S. Kmoch, S. Lyonnet, M. Zikanova,

. 2019 ; 28 (22) : 3805-3814. [pub] 20191115

Jazyk angličtina Země Velká Británie

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023481

We report for the first time an autosomal recessive inborn error of de novo purine synthesis (DNPS)-PAICS deficiency. We investigated two siblings from the Faroe Islands born with multiple malformations resulting in early neonatal death. Genetic analysis of affected individuals revealed a homozygous missense mutation in PAICS (c.158A>G; p.Lys53Arg) that affects the structure of the catalytic site of the bifunctional enzyme phosphoribosylaminoimidazole carboxylase (AIRC, EC 4.1.1.21)/phosphoribosylaminoimidazole succinocarboxamide synthetase (SAICARS, EC 6.3.2.6) (PAICS). The mutation reduced the catalytic activity of PAICS in heterozygous carrier and patient skin fibroblasts to approximately 50 and 10% of control levels, respectively. The catalytic activity of the corresponding recombinant enzyme protein carrying the mutation p.Lys53Arg expressed and purified from E. coli was reduced to approximately 25% of the wild-type enzyme. Similar to other two known DNPS defects-adenylosuccinate lyase deficiency and AICA-ribosiduria-the PAICS mutation prevented purinosome formation in the patient's skin fibroblasts, and this phenotype was corrected by transfection with the wild-type but not the mutated PAICS. Although aminoimidazole ribotide (AIR) and aminoimidazole riboside (AIr), the enzyme substrates that are predicted to accumulate in PAICS deficiency, were not detected in patient's fibroblasts, the cytotoxic effect of AIr on various cell lines was demonstrated. PAICS deficiency is a newly described disease that enhances our understanding of the DNPS pathway and should be considered in the diagnosis of families with recurrent spontaneous abortion or early neonatal death.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023481
003      
CZ-PrNML
005      
20201214130143.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/hmg/ddz237 $2 doi
035    __
$a (PubMed)31600779
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Pelet, Anna $u Laboratory Embryology and Genetics of Congenital Malformation, INSERM UMR1163, Imagine Institute, Université de Paris, F-75015 Paris, France.
245    10
$a PAICS deficiency, a new defect of de novo purine synthesis resulting in multiple congenital anomalies and fatal outcome / $c A. Pelet, V. Skopova, U. Steuerwald, V. Baresova, M. Zarhrate, JM. Plaza, A. Hnizda, M. Krijt, O. Souckova, F. Wibrand, G. Andorsdóttir, F. Joensen, D. Sedlak, AJ. Bleyer, S. Kmoch, S. Lyonnet, M. Zikanova,
520    9_
$a We report for the first time an autosomal recessive inborn error of de novo purine synthesis (DNPS)-PAICS deficiency. We investigated two siblings from the Faroe Islands born with multiple malformations resulting in early neonatal death. Genetic analysis of affected individuals revealed a homozygous missense mutation in PAICS (c.158A>G; p.Lys53Arg) that affects the structure of the catalytic site of the bifunctional enzyme phosphoribosylaminoimidazole carboxylase (AIRC, EC 4.1.1.21)/phosphoribosylaminoimidazole succinocarboxamide synthetase (SAICARS, EC 6.3.2.6) (PAICS). The mutation reduced the catalytic activity of PAICS in heterozygous carrier and patient skin fibroblasts to approximately 50 and 10% of control levels, respectively. The catalytic activity of the corresponding recombinant enzyme protein carrying the mutation p.Lys53Arg expressed and purified from E. coli was reduced to approximately 25% of the wild-type enzyme. Similar to other two known DNPS defects-adenylosuccinate lyase deficiency and AICA-ribosiduria-the PAICS mutation prevented purinosome formation in the patient's skin fibroblasts, and this phenotype was corrected by transfection with the wild-type but not the mutated PAICS. Although aminoimidazole ribotide (AIR) and aminoimidazole riboside (AIr), the enzyme substrates that are predicted to accumulate in PAICS deficiency, were not detected in patient's fibroblasts, the cytotoxic effect of AIr on various cell lines was demonstrated. PAICS deficiency is a newly described disease that enhances our understanding of the DNPS pathway and should be considered in the diagnosis of families with recurrent spontaneous abortion or early neonatal death.
650    _2
$a mnohočetné abnormality $x genetika $7 D000015
650    _2
$a adenylsukcinátlyasa $x nedostatek $7 D000264
650    _2
$a autistická porucha $7 D001321
650    _2
$a karboxylyasy $x genetika $x metabolismus $7 D002262
650    _2
$a fatální výsledek $7 D017809
650    _2
$a lidé $7 D006801
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mutace $7 D009154
650    _2
$a peptidsynthasy $x genetika $x metabolismus $7 D010453
650    _2
$a perinatální smrt $7 D066087
650    _2
$a fenotyp $7 D010641
650    _2
$a poruchy metabolismu purinů a pyrimidinů $7 D011686
650    _2
$a puriny $x biosyntéza $x metabolismus $7 D011687
651    _2
$a Dánsko $7 D003718
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Skopova, Vaclava $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic.
700    1_
$a Steuerwald, Ulrike $u Pediatric Unit, Medical Department, The Faroese Hospital System, FO 100 Tórshavn, Faroe Islands.
700    1_
$a Baresova, Veronika $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic.
700    1_
$a Zarhrate, Mohammed $u Laboratory Embryology and Genetics of Congenital Malformation, INSERM UMR1163, Imagine Institute, Université de Paris, F-75015 Paris, France.
700    1_
$a Plaza, Jean-Marc $u Laboratory Embryology and Genetics of Congenital Malformation, INSERM UMR1163, Imagine Institute, Université de Paris, F-75015 Paris, France.
700    1_
$a Hnizda, Ales $u Department of Biochemistry, University of Cambridge, CB2 1TN Cambridge, UK.
700    1_
$a Krijt, Matyas $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic.
700    1_
$a Souckova, Olga $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic.
700    1_
$a Wibrand, Flemming $u Department of Clinical Genetics, Rigshospitalet, 2100 Copenhagen, Denmark.
700    1_
$a Andorsdóttir, Guðrið $u FarGen, The Genetic Biobank of the Faroe Islands, FO 100 Tórshavn, Faroe Islands.
700    1_
$a Joensen, Fróði $u Pediatric Unit, Medical Department, The Faroese Hospital System, FO 100 Tórshavn, Faroe Islands.
700    1_
$a Sedlak, David $u CZ-OPENSCREEN, Institute of Molecular Genetics, Czech Academy of Sciences, 140 00 Prague, Czech Republic.
700    1_
$a Bleyer, Anthony J $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic. Section on Nephrology, Wake Forest School of Medicine, 271 03 Winston-Salem, NC, USA.
700    1_
$a Kmoch, Stanislav $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic.
700    1_
$a Lyonnet, Stanislas $u Laboratory Embryology and Genetics of Congenital Malformation, INSERM UMR1163, Imagine Institute, Université de Paris, F-75015 Paris, France.
700    1_
$a Zikanova, Marie $u Research Unit for Rare Diseases, Department of Paediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, 12808 Prague, Czech Republic.
773    0_
$w MED00002077 $t Human molecular genetics $x 1460-2083 $g Roč. 28, č. 22 (2019), s. 3805-3814
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31600779 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20201214130141 $b ABA008
999    __
$a ok $b bmc $g 1595800 $s 1114157
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 28 $c 22 $d 3805-3814 $e 20191115 $i 1460-2083 $m Human molecular genetics $n Hum Mol Genet $x MED00002077
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...